Hetero signs deal with Russia to make COVID-19 vaccine Sputnik V in India

The vaccine, announced earlier this week by Russia’s sovereign wealth fund, claims an “interim efficacy” of 91.4%, from its ongoing phase-3 trials

Similar Articles

Most Popular